92 related articles for article (PubMed ID: 8549392)
1. Comparison of ciprofloxacin with imipenem in the treatment of severe pneumonia in hospitalised geriatric patients.
Siami GA; Wilkins WT; Bess DT; Christman JW
Drugs; 1995; 49 Suppl 2():436-8. PubMed ID: 8549392
[No Abstract] [Full Text] [Related]
2. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Caldwell JW; Singh S; Johnson RH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
Torres A; Bauer TT; León-Gil C; Castillo F; Alvarez-Lerma F; Martínez-Pellús A; Leal-Noval SR; Nadal P; Palomar M; Blanquer J; Ros F
Thorax; 2000 Dec; 55(12):1033-9. PubMed ID: 11083889
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin.
Snydman D; Fink M; Niederman M; Reinhart H
Drugs; 1995; 49 Suppl 2():439-41. PubMed ID: 8549393
[No Abstract] [Full Text] [Related]
5. Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
Walters DJ; Solomkin JS; Paladino JA
Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):551-61. PubMed ID: 10662480
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of ciprofloxacin with biapenem in patients with moderate or severe pneumonia].
Rikimaru T; Yonemitu J; Koga T; Shimada A; Yokoyama T; Kawayama T; Kamimura T; Aizawa H
Kansenshogaku Zasshi; 2007 May; 81(3):276-83. PubMed ID: 17564116
[TBL] [Abstract][Full Text] [Related]
7. Emergence of different resistance mechanisms in Pseudomonas aeruginosa in a patient treated with imipenem.
Miró E; Navarro F; March F; Sanchez F; Mirelis B
Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):731-2. PubMed ID: 8566000
[No Abstract] [Full Text] [Related]
8. In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.
Joly-Guillou ML; Wolff M; Farinotti R; Bryskier A; Carbon C
J Antimicrob Chemother; 2000 Nov; 46(5):827-30. PubMed ID: 11062208
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe pneumonia with ciprofloxacin or imipenem.
Wood CA
Antimicrob Agents Chemother; 1994 Aug; 38(8):1871-2. PubMed ID: 7986025
[No Abstract] [Full Text] [Related]
10. Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
Ho A; Leung R; Lai CK; Chan TH; Chan CH
Respiration; 1997; 64(3):224-8. PubMed ID: 9154675
[TBL] [Abstract][Full Text] [Related]
11. Quinolones for treatment of nosocomial pneumonia: a meta-analysis.
Shorr AF; Susla GB; Kollef MH
Clin Infect Dis; 2005 Feb; 40 Suppl 2():S115-22. PubMed ID: 15712099
[TBL] [Abstract][Full Text] [Related]
12. Neonatal community-acquired pneumonia: pathogens and treatment.
Wang H; Tang J; Xiong Y; Li X; Gonzalez F; Mu D
J Paediatr Child Health; 2010 Nov; 46(11):668-72. PubMed ID: 20796185
[TBL] [Abstract][Full Text] [Related]
13. "Ciprofloxacin: a warning for clinicians".
Breck RW
Conn Med; 2002 Oct; 66(10):635. PubMed ID: 12448217
[No Abstract] [Full Text] [Related]
14. Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Winston DJ; Lazarus HM; Beveridge RA; Hathorn JW; Gucalp R; Ramphal R; Chow AW; Ho WG; Horn R; Feld R; Louie TJ; Territo MC; Blumer JL; Tack KJ
Clin Infect Dis; 2001 Feb; 32(3):381-90. PubMed ID: 11170945
[TBL] [Abstract][Full Text] [Related]
15. [The effect of intravenous ciprofloxacin for community acquired pneumonia in adults].
Fujita M; Ishibashi T; Hara N; Yoshida M; Yamada H;
Jpn J Antibiot; 2003 Aug; 56(4):289-93. PubMed ID: 14567253
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
Shorr AF; Zadeikis N; Jackson WL; Ramage AS; Wu SC; Tennenberg AM; Kollef MH
Clin Infect Dis; 2005 Feb; 40 Suppl 2():S123-9. PubMed ID: 15712100
[TBL] [Abstract][Full Text] [Related]
17. Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.
Romanelli G; Cravarezza P; Pozzi A; Franchino L; Ravizzola G; Zulli R; Donati P; Prometti P; Grassi V
J Chemother; 2002 Dec; 14(6):609-17. PubMed ID: 12583553
[TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs.
Schirmer PL; Mercier RC; Ryono RA; Nguyen N; Lucero CA; Oda G; Holodniy M
Infect Control Hosp Epidemiol; 2012 Apr; 33(4):409-11. PubMed ID: 22418639
[TBL] [Abstract][Full Text] [Related]
19. [Clinical of 50 cases of aged patients with pneumonia caused by gram-negative bacteria].
Xiao Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):187-8. PubMed ID: 10681842
[TBL] [Abstract][Full Text] [Related]
20. Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia.
Marklein G
Chemotherapy; 1996 Mar; 42 Suppl 1():33-42. PubMed ID: 8861533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
